Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.
about
Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsidePositron emission tomography to assess hypoxia and perfusion in lung cancerPET Metabolic Biomarkers for CancerCT-perfusion versus [(15)O]H2O PET in lung tumors: effects of CT-perfusion methodology.Assessing Treatment Response Through Generalized Pharmacokinetic Modeling of DCE-MRI Data.Renal MR angiography and perfusion in the pig using hyperpolarized water.Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sourcesTargeted therapies in renal cell cancer: recent developments in imagingHyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancerTumor Vascular Permeability Pattern Is Associated With Complete Response in Immunocompetent Patients With Newly Diagnosed Primary Central Nervous System Lymphoma: Retrospective Cohort Study.Has quantitative multimodal imaging of treatment response arrived?Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review.Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials.Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.Hypoxia in cervical cancer: from biology to imaging.Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical ImagingQuantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography.Cardiac perfusion imaging using hyperpolarized (13)C urea using flow sensitizing gradients.Simultaneous multiagent hyperpolarized (13)C perfusion imaging.Molecular and clinical aspects of targeting the VEGF pathway in tumors.Phenomenological model of interstitial fluid pressure in a solid tumor.Development of a method for functional aspect identification in parotid using dynamic contrast-enhanced magnetic resonance imaging and concurrent stimulation.Linearization improves the repeatability of quantitative dynamic contrast-enhanced MRI.
P2860
Q26752752-BC604848-1A63-4C0B-8379-CBDAFB434018Q26770678-72D47CF0-8732-4B52-B92C-8560908F7F66Q27026940-30425957-015E-45FE-AE21-F8ADE413FA13Q28074449-8E3C95D0-AF8C-4580-9441-BCE265F2B8A0Q30620750-1841CB50-41BC-43C1-9D7A-0B146FC57BA4Q30990964-34EBEA29-4F0D-4A82-814E-1368A94C9D13Q31134064-E8758477-7FD7-450F-B95B-944517ACC61BQ33517098-D453D44D-F790-4BBC-8D10-32659DFFF178Q34088696-827C8628-CA51-49BF-86B4-C0DE715B1723Q34120237-E5BC7798-DA59-470E-A69A-CA798550D671Q34538659-E0593B69-ED1C-47EE-859B-BC604D41176BQ36580868-31F8D5D6-4AC1-4538-8EFF-0FBDE96F53A8Q37439058-85A4CDF4-0D4E-4091-BF7B-99DE7F1E9A8FQ37871859-BA8E5216-4C7C-4DC7-9C58-D9530D4F10AFQ38000044-1E015602-40B6-478D-A565-5B672DAF9674Q38325752-0BD88DA8-63C5-4E84-8D73-BFBC36837841Q38643119-E9591FD0-C5DE-45C0-8DE8-74DE8B9AA5ECQ38936273-12FCD1FD-AC64-4864-B038-1FA8F3DFAE4CQ39135714-02651C80-5452-4251-B3CF-14A1D2AEC007Q41114248-945DD789-D4E0-416E-B1C2-1975072B7609Q41872387-AEEE3D82-315A-4015-8877-F3EDB12259B8Q42088955-30F640B1-76E6-468F-9B1F-32A288D248C3Q42121924-A950C8EB-1FF6-4671-854A-8FC0E1640B08Q42444375-CFECCD2A-4434-428C-984E-2D8A1FE7C8F2Q46085180-49CADA0B-0FB5-4D3F-95F2-1DFB662D8FA3Q47332679-F6EA154C-D4A4-41A7-8D55-006F5586613F
P2860
Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.
@en
type
label
Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.
@en
prefLabel
Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.
@en
P2093
P1433
P1476
Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.
@en
P2093
Adrianus J de Langen
J Tim Marcus
Mark Lubberink
Vivian E M van den Boogaart
P304
P356
10.1634/THEONCOLOGIST.2007-0235
P577
2008-06-01T00:00:00Z